Brexanolone Rapidly Improves Postpartum Depression, Anxiety, and Sleep

How Effective Is Brexanolone for Postpartum Depression and Related Symptoms?

A pooled analysis of three double-blind, randomized, placebo-controlled trials in the HUMMINGBIRD clinical program demonstrates that brexanolone infusion provides rapid and sustained improvement in depressive symptoms, anxiety, and insomnia in women with postpartum depression. Published in the Journal of Affective Disorders, this comprehensive analysis shows that brexanolone is associated with rapid improvement in depressive symptoms, with treatment effects sustained post-infusion, offering hope for mothers experiencing this debilitating condition.

Read more

Real-World Brexanolone Outcomes: 12-Month Follow-Up Shows Sustained Benefits

Does brexanolone work for postpartum depression in real practice?

Brexanolone shows sustained effectiveness for postpartum depression in real-world clinical practice with benefits lasting 12+ months. Study of 150 women demonstrates consistent outcomes.

Brexanolone works by rapidly restoring GABAergic function that's disrupted in postpartum depression, providing quick relief through IV infusion for severe cases.

What the data show:

• Real-world setting: works in complex clinical practice settings
• Duration of benefit: improvements maintained for 12+ months
• Complex patients: effective even with comorbidities and complications
• Treatment delivery: IV infusion provides rapid relief for severe postpartum depression
• Evidence level: crucial real-world data beyond controlled trials

A real-world effectiveness study published in Women’s Health Reports examined outcomes in 150 women receiving brexanolone treatment, showing that brexanolone maintains its effectiveness in clinical practice where patients have more complex presentations than typical research populations.

Read more